Haisco Pharmaceutical Group's high P/E ratio is concerning d...
Haisco Pharmaceutical Group's high P/E ratio is concerning due to its poor earnings forecast. The inflated P/E from recent momentum may not be sustainable, posing a risk to shareholders and potential investors.
![](https://pubimg-10000538.picsh.myqcloud.com/2022050900000241e2c3614fabb.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment